Cite
HARVARD Citation
Conteduca, V. et al. (2021). Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study. European journal of cancer. pp. 49-59. [Online].